- Home
- NWBI vs QURE Comparison
NWBI vs QURE Comparison
Compare NWBI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWBI | QURE |
|---|---|---|
| Founded | 1896 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NWBI | QURE |
|---|---|---|
| Price | $11.96 | $27.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $15.00 | ★ $62.33 |
| AVG Volume (30 Days) | 921.6K | ★ 4.7M |
| Earning Date | 10-27-2025 | 11-10-2025 |
| Dividend Yield | ★ 6.70% | N/A |
| EPS Growth | ★ 13.78 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $564,562,000.00 | $15,751,000.00 |
| Revenue This Year | $7.26 | N/A |
| Revenue Next Year | $13.90 | $229.18 |
| P/E Ratio | $13.83 | ★ N/A |
| Revenue Growth | ★ 15.71 | N/A |
| 52 Week Low | $10.75 | $5.89 |
| 52 Week High | $15.03 | $71.50 |
Technical Indicators
Market Signals| Indicator | NWBI | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 33.83 |
| Support Level | $11.25 | $26.76 |
| Resistance Level | $12.28 | $28.50 |
| Average True Range (ATR) | 0.26 | 2.55 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 67.96 | 35.70 |
Price Performance
Historical ComparisonAbout NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.